Jade Biosciences, Inc. Common Stock
JBIO • NASDAQ
Jade Biosciences, Inc. Common Stock is a pharmaceutical preparations company on NASDAQ, with a market cap of $689.1M. As of Q3 2025, 97% of shares are held by 74 institutional investors, with FMR LLC as the largest holder at 14.98%.
Overview
Overview of institutional ownership in JBIO as of Q3 2025 with a market cap of $281.6M
All Institutions
- Institutions
- 74
- Value Held
- $272.9M
- Shares Held
- 31.6M
- Avg Position
- $3.7M
- Median Position
- $213.5K
Hedge Funds
- Hedge Funds
- 14
- Value Held
- $112.3M
- Shares Held
- 13.0M
- Avg Position
- $8.0M
- Median Position
- $6.1M
Ownership Breakdown
Based on market cap of $281.6M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Biggest Investors
Institutions with the largest positions in JBIO as of Q3 2025
| Institution | Position Value |
|---|---|
 FMR LLC Institution | $42.2M 0.00% of portfolio |
 Fairmount Funds Management LLC Hedge Fund•Sector | $27.8M 2.50% of portfolio |
 VR Adviser, LLC Venture Capital | $27.8M 1.56% of portfolio |
 Deep Track Capital, LP Hedge Fund•Long/Short | $19.7M 0.56% of portfolio |
B BlackRock, Inc. Institution | $18.6M 0.00% of portfolio |
 VANGUARD GROUP INC Institution | $14.9M 0.00% of portfolio |
V Versant Venture Management, LLC Institution | $13.2M 6.20% of portfolio |
 RTW INVESTMENTS, LLC Hedge Fund•Sector | $12.5M 0.16% of portfolio |
 Frazier Life Sciences Management, L.P. Venture Capital | $12.2M 0.37% of portfolio |
 DRIEHAUS CAPITAL MANAGEMENT LLC Hedge Fund•Event Driven | $10.8M 0.08% of portfolio |
Net Capital Flow
Institutional buying and selling activity for JBIO in Q3 2025
- Traded
- +$444.5K
- Buyers
- 30
- Sellers
- 27
- Total Bought
- +$10.8M
- Total Sold
- −$10.3M
- Avg Position
- $3.3M
Biggest Buyers
| Institution | Net Bought |
|---|---|
B BlackRock, Inc. Institution | +$3.8M +435.9K shares |
 STATE STREET CORP Institution | +$1.6M +180.5K shares |
 GOLDMAN SACHS GROUP INC Institution | +$1.4M +162.7K shares |
G GREAT POINT PARTNERS LLC Private Equity | +$1.2M +134.5K shares |
 WELLINGTON MANAGEMENT CO LLP Long Only Manager | +$928.2K +107.6K shares |
FMR LLC Institution | +$460.8K +53.4K shares |
 Marshall Wace LLP Institution | +$328.6K +38.1K shares |
 Invesco Ltd. ETF Provider | +$298.4K +34.6K shares |
 TWO SIGMA INVESTMENTS LLC Hedge Fund•Multi-Strategy | +$212.4K +24.6K shares |
X XTX Topco Ltd Institution | +$125.5K +14.5K shares |
Biggest Sellers
| Institution | Net Sold |
|---|---|
Frazier Life Sciences Management, L.P. Venture Capital | −$3.1M −358.8K shares |
Deep Track Capital, LP Hedge Fund•Long/Short | −$2.0M −229.4K shares |
 BARCLAYS PLC Institution | −$2.0M −229.1K shares |
 Woodline Partners LP Hedge Fund•Long/Short | −$1.1M −106.3K shares |
VANGUARD GROUP INC Institution | −$697.6K −80.8K shares |
 TCG Crossover Management, LLC Venture Capital | −$639.6K −64.0K shares |
 SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | −$186.2K −21.6K shares |
N Nuveen, LLC Institution | −$150.0K −17.4K shares |
 CITIGROUP INC Institution | −$91.1K −10.6K shares |
 GEODE CAPITAL MANAGEMENT LLC ETF Provider | −$90.8K −10.5K shares |
Entry and Exit Activity
Institutions that initiated new positions or completely exited JBIO in Q3 2025
- New Positions
- 4
- New Value
- $1.4M
- Exited Positions
- 5
- Exited Value
- $1.8M
New Positions
| Institution | Position Value |
|---|---|
WELLINGTON MANAGEMENT CO LLP Long Only Manager | $928.2K 107.6K shares |
Marshall Wace LLP Institution | $328.6K 38.1K shares |
 MetLife Investment Advisors, LLC Insurance Manager | $114.6K 13.3K shares |
 NISA INVESTMENT ADVISORS L L C Long Only Manager | $371.0 43.0 shares |
Exited Positions
| Institution | Previous Position |
|---|---|
Woodline Partners LP Hedge Fund•Long/Short | $1.1M 106.3K shares |
TCG Crossover Management, LLC Venture Capital | $639.6K 64.0K shares |
 Kovitz Investment Group Partners, LLC RIA/Wealth | $64.9K 24.2K shares |
 Glenmede Investment Management, LP Long Only Manager | $529.0 53.0 shares |
A Alamea Verwaltungs GmbH Institution | $512.0 204.0 shares |
Options Activity
Institutions with the largest Call and Put options positions in JBIO as of Q3 2025
- Call Positions
- 0
- Call Value
- -
- Put Positions
- 2
- Put Value
- $497.3K
Call Positions
| Institution | Position Value |
|---|---|
| No call positions found | |
Put Positions
| Institution | Position Value |
|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $494.5K 573.0 contracts |
 DIADEMA PARTNERS LP Hedge Fund•Long/Short | $2.8K 10.5 contracts |
Most Committed Institutions
Institutions with JBIO as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
V Versant Venture Management, LLC Institution | 6.20% $13.2M |
Fairmount Funds Management LLC Hedge Fund•Sector | 2.50% $27.8M |
G GREAT POINT PARTNERS LLC Private Equity | 2.41% $5.5M |
A Avidity Partners Management LP Hedge Fund•Long/Short | 2.27% $9.7M |
VR Adviser, LLC Venture Capital | 1.56% $27.8M |
 Samsara BioCapital, LLC Venture Capital | 0.60% $4.6M |
Deep Track Capital, LP Hedge Fund•Long/Short | 0.56% $19.7M |
 Logos Global Management LP Hedge Fund•Long/Short | 0.55% $5.4M |
 Soleus Capital Management, L.P. Hedge Fund•Long/Short | 0.38% $6.9M |
Frazier Life Sciences Management, L.P. Venture Capital | 0.37% $12.2M |
Hedge Fund Spotlight
Discover hedge funds investing in JBIO
Soleus Capital Management, L.P.
Hedge Fund • Long/Short
Portfolio ManagerGuy Bezalel Levy
- Portfolio Value
- $1.8B
- Positions
- 85
- Last Reported
- Q3 2025
Sector Allocation
Position in Jade Biosciences, Inc. Common Stock
- Market Value
- $6.9M
- Shares Held
- 796.7K
- Portfolio Weight
- 0.38%
- Owned Since
- 2025-Q2
| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Biotechnology Healthcare | $179.9M | 9.82% | |
Biotechnology Healthcare | $138.9M | 7.59% | |
Medical - Instruments & Supplies Healthcare | $124.6M | 6.81% |
